Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Late Breaking


46,XY DSD due to Isolated AMH Deficiency Resulting in Persistent Mullerian Duct Syndrome (PMDS) as a Consequence of a Single-Base Deletion in a SF1-Response Element of the AMH promoter
aCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina; bUniversité Paris Diderot, Sorbonne Paris Cité, F-75013 Paris, France; INSERM U1133, Physiologie de l’Axe Gonadotrope, F-75013 Paris, France; CNRS, UMR8251, Biologie Fonctionnelle et Adaptative, Paris, France; cDivision of Pediatric Endocrinology, Rutgers – Robert Wood Johnson Medical School, Child Health Institute of New Jersey, New Brunswick, NJ, USA; dDepartamento de Histología, Biología Celular, Embriología y Genética, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
The Growth Hormone - Insulin Like Growth Factor I (IGF-1) System in Early Non-Alcoholic Fatty Liver Disease: From an Animal Model to a Children's Cohort
aCenter for Pediatric Research, University Hospital for Children and Adolescents Leipzig, University of Leipzig, Leipzig, Germany; bLIFE Leipzig Research Centre for Civilization Diseases, University of Leipzig, 04103 Leipzig, Germany; cDepartment of Medicine, Division of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany
Development of Skeletal Microarchitecture and Biomechanics Over 2 Years Following 6 Month Intragastric Balloon Insertion in Obese Adolescents
aDepartment of Paediatric Endocrinology, Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UK; bAcademic Unit of Child health, University of Sheffield, Sheffield, UK; cCentre for Sport and Exercise Science, Sheffield Hallam University, Sheffield, UK; dCentre for Paediatric Gastroenterology, Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UK; eLady Cilento Children’s Hospital, Queensland, Australia; fSchool of Health and Related Research, University of Sheffield, Sheffield, UK
Loss of Functional Osteoprotegerin: More than a Skeletal Problem
aPediatric Endocrinology and Diabetology, University Hospital Essen, Essen, Germany; bUniversity Hospital Essen, Center for Rare Bone Disease, Essen, Germany; cDepartment of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany; dDepartment of Orthopedic Surgery, Unviversity Hospital Essen, Essen, Germany; eDepartment of ENT, University Hospital Essen, Essen, Germany; fDepartment of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK; gChildren’s Hospital Düsseldorf, Düsseldorf, Germany; hUniversity of Freiburg, Division of Pediatric Genetics, Freiburg, Germany
Impact of Weight Loss after Bariatric Surgery on Gonadic Function in Severely Obese Female Adolescents
aPaediatric Endocrinology, Lille University Hospital, Lille, France; bPaediatric Surgery, Lille University Hospital, Lille, France; cUpper Limb Orthopaedic Surgery, Lille University Hospital, Lille, France; dDepartment of General and Endocrine Surgery, Lille University Hospital, Lille, France; eDepartment of Nutrition, Lille University Hospital, Lille, France
Osteoprotegerin and Insulin Resistance in Childhood Obesity: A New Interplay?
a4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece; bLaboratory of Biological Chemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
Molecular Analysis of AR, SRD5A2, NR5A1 and HSD17B3 Genes in a Brazilian 46,XY DSD Cohort
aUniversidade Federal de Alagoas, Maceió, Alagoas, Brazil; bUniversidade Estadual de Campinas, Campinas, São Paulo, Brazil; cUniversidade Estadual de Ciências da Saúde de Alagoas, Maceió, Alagoas, Brazil
Long-Term Safety and Effectiveness of Growth Hormone Treatment in Pediatric Patients with Growth Hormone Deficiency: Interim Results of LG Growth Study
aDepartment of Pediatrics, Konkuk University School of Medicine, Seoul, Republic of Korea; bDepartment of Pediatrics, College of Medicine, Hallym University, Seoul, Republic of Korea; cDepartment of Pediatrics, Korea University Ansan Hospital, Gyenggi-Do, Republic of Korea; dDepartment of Pediatrics, Inje University College of Mecine, Ilsan Paik Hospital, Goyang-si, Gyeonggi-do, Republic of Korea; eDepartment of Pediatrics, Gangnam Severance Hospital, Seoul, Republic of Korea; fDepartment of Pediatrics, Asan Medical Center, Seoul, Republic of Korea; gDepartment of Pediatrics, Dong-A University Medical Center, Busan, Republic of Korea; hDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea
An Analysis of Symptoms and Signs of Adrenal Insufficiency in Children with CAH Admitted to Hospital in Australia
aThe University of Notre Dame Australia, Sydney, NSW, Australia; bThe Children’s Hospital at Westmead, Sydney, NSW, Australia; cKarolinska University Hospital, Stockholm, Sweden; dKarolinska Institutet, Stockholm, Sweden; eThe University of Sydney, Sydney, NSW, Australia; fSydney Children’s Hospital, Randwick, Sydney, NSW, Australia; gUniversity of New South Wales, Sydney, NSW, Australia; hJohn Hunter Children’s Hospital, Newcastle, NSW, Australia; iThe University of Newcastle, Australia, Newcastle, NSW, Australia; jRoyal Adelaide Hospital, Adelaide, SA, Australia; kUniversity of Adelaide, Adelaide, SA, Australia
Hyperprolactinemia in Children and Adolescents: A Review of Patients Presenting to a Tertiary Center in Australia
aThe Children’s Hospital at Westmead, Westmead, NSW, Australia; bUniversity of Sydney, Sydney, NSW, Australia